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450a Tuesday, February 5, 2013double-labeled with 2-(4’-(2’’-iodoacetamido)phenyl)aminonaphthalene-6-
sulfonic acid (IAANS) was greater at higher temperatures, i.e. 0.11, 0.25 and
0.66 log units at 21, 30 and 45C respectively. In cardiac skinned fibers at
higher temperatures, Ca2þ binding affinity (-log Ca50) was further increased
for D145E (from pCa50 5.5550.01 at 15C to 6.3450.02 at 30C) than for
WT (pCa50 5.3950.01 at 15C to 5.9650.04 at 30C), so that DpCa50 mea-
sured at different temperatures increased in a linear fashion. Maximal tension
(P0) was markedly lower for D145E compared to WT at 30C. These data in-
dicate that D145E´s instability dictates its impaired function within the physio-
logical milieu. NIH-HL103840 (JRP)2303-Pos Board B322
Remote Ischemic Conditioning Restores Contractile defect Following
Ischemia by Reversing Ischemia-Induced Decreases in Phosphorylation
of Sarcomeric Proteins
Young S. Han, Ozgur Ogut.
Mayo Clinic College of Medicine, Rochester, MN, USA.
Non-invasive remote ischemic conditioning, repetitive brief ischemia of the
arm or leg through alternating inflation and deflation of a blood-pressure
cuff, has been demonstrated to produce cardioprotection in animal models
and in clinical studies. Our previous study using an in vivo rat ischemia model
demonstrated a decrease in maximal force per cross-sectional area (Fmax) and
the rate constant of force activation (kact) following flash photolysis of caged
Ca2þ (NP-EGTA), which correlated with a decrease in phosphorylation of tro-
ponin I (TnI) and myosin binding protein-C (MyBP-C), important regulators of
muscle contraction and targets of the cAMP-dependent protein kinase (PKA)
upon b-adrenergic receptor (b-AR) stimulation. Therefore, we hypothesized
that remote ischemic conditioning would mitigate the decrease in mechanical
function following acute ischemia by reversing ischemia-derived decreases
in phosphorylation of sarcomeric proteins and/or of PKA subunits. To test
this hypothesis, we examined Fmax, kact, and phosphorylation status of
MyBP-C, TnT, TnI, and PKA subunits in control, ischemic and conditioned
rat myocardia. Remote ischemic conditioning was simultaneously applied to
experimental rats undergoing 30-min acute myocardial ischemia with LAD
ligation by executing 3 cycles of 5-min inflation and deflation of a blood-
pressure cuff mounted on the left hind limb. Our data show that remote ische-
mic conditioning significantly blunts the reduction in Fmax (72.5 5 4.9 vs
53.7 5 3.4 vs 64.9 5 2.4 mN/mm2; control vs ischemic vs conditioned,
n=9; P< 0.05) and in kact (24.45 1.9 vs 19.15 1.0 vs 23.15 1.1 s
1; control
vs ischemic vs conditioned, n=9; P < 0.05), which correlates with reversal of
ischemia-derived decreases in phosphorylation of target proteins of PKA.
These data suggest that remote conditioning merits additional study for its
beneficial role in ischemia-induced myocardial dysfunction.2304-Pos Board B323
Mechanistic Understanding of the Involvement of MyBP-C Slow in the
Development of Distal Arthrogryposis
Maegen A. Ackermann, Minerva Contreras, Puja D. Patel,
Aikaterini Kontrogianni-Konstantopoulos.
University of Maryland, Baltimore, MD, USA.
Myosin Binding Protein-C (MyBP-C), expressed in striated muscles, is a thick
filament associated protein that plays important roles in thick filament assembly
and stabilization, and the modulation of actomyosin cross-bridges formation.
Several studies have implicated MyBP-C in the development of cardiac and
recently skeletal myopathies, underlining its importance in normal sarcomeric
function. Mutations in the slow skeletal isoform of MyBP-C (sMyBP-C) have
been causally linked to severe and lethal forms of arthrogryposis, a family of
neuromuscular diseases. Two missense mutations within MYBPC1, the gene
that encodes sMyBP-C, located within the NH2-terminal M-motif (W236R)
and the COOH-terminal immunoglobulin (Ig) C8 domain (Y856H) have
been linked to the development of distal arthrogryposis type-1 (DA-1), a skel-
etal muscle disorder characterized by contractures of the distal limbs. Here we
explore the molecular defects that underlie the development of DA-1. using
a combination of in vitro binding and motility assays, we show that the pres-
ence of the W236R mutation abolishes the ability of the NH2-terminus to mod-
ulate the formation of actomyosin cross-bridges, while the presence of the
Y856H mutation inhibits Ig domains C8-C10 from interacting with native
myosin filaments. Our findings therefore suggest that distinct mechanisms
may underlie the pathogenesis of DA-1 myopathy depending on the location
of the individual mutation within sMyBP-C. We are currently examining the
effects of overexpressing mutant sMyBP-C proteins carrying either the
W236R or the Y856H mutation in a sMyBP-C-null background, via in vivo
gene transfer. In summary, our studies are the first to provide a mechanistic
interpretation of the pathogenesis of distal arthrogryposis.2305-Pos Board B324
How Muscle Exploits the Steady State to Regulate Contraction
Henry G. Zot1, Javier E. Hasbun1, Nguyen Van Minh2.
1University of West Georgia, Carrollton, GA, USA, 2Columbus State
University, Columbus, GA, USA.
Activation of muscle requires myosin binding. The active state of muscle is sta-
bilized by high affinity rigor bonds at equilibrium but, the steady-state catalytic
cycle of myosin ATPase decreases the lifetime of the myosin interaction by
several orders of magnitude. Low myosin affinity could be a justification for
including Ca2þ binding states in a model of activation. Our work supports
a simple model for steady state activation, namely, the regulatory protein tropo-
myosin (Tm) exists in just two states, ground (C) and excited (M), separated by
an energy barrier which can be overcome by interaction with myosin. The elon-
gated shape of Tm allows for multiple potential myosin binding partners (Ui).
During its strong binding phase of the catalytic cycle, any one myosin (U1)
combines with C to form M by an equilibrium pathway. At time, t=0, M prob-
ability, PM=1. Although U1 most likely decays by a non-equilibrium rate (i.e.,
ATP binding), the lifetime of PM is constant. For t>0, before M decays to C,
interaction with Ui in the strong binding phase can restore PM=1. We show
that an analytical function (M function) is fully derived from the combination
of equilibrium and steady state pathways and the additional opportunities
(second chances) to restore PM=1 depend on the rate at which Ui transitions
into the strong binding phase. When Ca2þ is introduced as a mass action reg-
ulator of the U or C supply, the M function takes the general form of the
Hill equation, which is widely employed for fitting the steady state response
of muscle to Ca2þ. We show by simulations that stochastic events predicted
by a second chance mechanism are consistent with solutions to the M function.
Our results justify kinetic experiments that focus specifically on M.
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Troponin I Serine 150 Phosphorylation Inhibits pH-Induced Troponin
Calcium Desensitization
Benjamin R. Nixon, Shane D. Walton, Sean C. Little, Jonathan P. Davis,
Brandon J. Biesiadecki.
The Ohio State University, Columbus, OH, USA.
A hallmark of cardiac ischemia is decreased intracellular pH which can affect
a number of cellular processes. Such an acidic environment alters cardiac tro-
ponin (Tn) myofilament regulation to decrease the Ca2þ sensitivity of force
production. Tn also undergoes cardiac ischemic-induced AMPK troponin I
(TnI) Ser-150 phosphorylation. We recently characterized the effect of TnI
Ser-150 phosphorylation demonstrating it to increase myofilament Ca2þ sensi-
tivity and blunt TnI PKA phosphorylation-induced desensitization. The effect
of an acidic environment on Tn myofilament regulation in the presence of
the ischemic-induced TnI Ser-150 phosphorylation is unknown. In this study
we investigate the effect of pH on myofilament regulation in the presence of
TnI Ser-150 phosphorylation. Myofilament regulation was determined by mea-
suring troponin C Ca2þ binding properties at normal and acidic pH. Results
demonstrate acidic pH decreases steady-state Ca2þ binding to troponin C in
thin filaments reconstituted with either WT or Ser-150 pseudo-phosphorylated
TnI (Tn S150D) such that Tn S150D Ca2þ sensitivity at pH 6.5 is similar to WT
at pH 7. Furthermore, while Tn S150D slowed Ca2þ dissociation compared to
Tn WT at pH 7.0, decreasing the pH to 6.5 did not further alter isolated Tn
S150D Ca2þ dissociation indicating a lack of pH to modulate Tn Ca2þ disso-
ciation kinetics. Thin filament dissociation kinetics are ongoing. We conclude
that TnI Ser-150 phosphorylation imparts resistance to acidic pH induced myo-
filament Ca2þ desensitization similar to that present during ischemia without
alteration of Tn Ca2þ dissociation. Future investigations are aimed at examin-
ing the effect of TnI Ser-150 phosphorylation in the presence of TnI Ser-23/24
phosphorylation at low pH.
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Phosphate Enhances Regulated Thin Filament Velocity at Acidic pH in the
Motility Assay
Thomas J. Longyear1, Matthew A. Turner1, Joseph Lopez2,
Jonathan P. Davis2, Edward P. Debold1.
1University of Massachusetts, Amherst, MA, USA, 2The Ohio State
University, Columbus, OH, USA.
Elevated levels of inorganic phosphate (Pi) and hydrogen ions (H
þ) are putative
agents of muscle fatigue. However, the molecular mechanisms underlying their
inhibitory action on the contractile proteins remains unclear. To gain mechanis-
tic insight into the effects of these ions on the myofilament function, we studied
their impact on the velocity-pCa relationship in an in vitro motility assay.
In this assay, actin filaments reconstituted with fast skeletal troponin (Tn)
and tropomyosin (Tm) moved on a coverslip surface coated with skeletal
myosin. At saturating Ca2þ (pCa5), decreasing the pH from 7.4 to 6.8 and
Tuesday, February 5, 2013 451a6.5 significantly (p<0.05) reduced filament velocity by 47 and 95%, respec-
tively. In addition, filament velocity was depressed at any given submaximal
Ca2þ level with the effect significantly more pronounced at pH 6.5 vs 6.8. How-
ever, the pCa50 increased significantly (p<0.05) when the pH was reduced from
7.4 to 6.8 (6.7650.07 vs. 7.6250.14) but was not significantly affected at pH
6.5 (6.6250.82). This suggests a complex relationship between pH and Ca2þ-
sensitivity. The addition of Pi had no effect on filament velocity at pH 7.4 but
significantly reversed the acidosis-induced depression in velocity at both pH
6.8 and 6.5, at every level of Ca2þ from pCa 7.0 to pCa 5.0. The addition of
Pi also increased the pCa50 at pH 6.5 from 6.6250.82 to 7.7450.20. The ef-
fects of these ions on regulated thin filament velocity are significantly more
pronounced than those observed with unregulated actin filaments (Debold
et al., 2011); therefore, we are now attempting to identify the structural regions
responsible by assessing the functional impact of structural alterations to key
regions of Tn.
2308-Pos Board B327
Maximum Activation of Thin Filaments at High Ionic Strength requires
Bound Calcium and Rigor Myosin
David H. Heeley1, Betty Belknap2, Howard D. White2.
1Memorial University, St. John’s, NL, Canada, 2Eastern Virginia Medical
School, Norfolk, VA, USA.
We have used stopped-flow fluorescence to measure the acceleration of disso-
ciation of hydrolysis products, Pi and deoxymantADP (mdADP), from
myosinS1-mdADP-Pi and myosinS1-mdADP by native cardiac thin filaments
(TF) at near physiological ionic strength (0.1M KAc). Although the rate con-
stants of the product dissociation steps cannot be measured at this ionic
strength, there is a linear dependence of the kobs of product (Pr = mdADP or
mdADP-Pi) dissociation (TF þ M-Pr4 TF-M-Pr/ TF-M þ Pr) on [TF],
which can be used to determine the dependence of the apparent second
order rate constant upon the ligands calcium and rigor myosin. The second
order rate constant of the dependence of the kobs of Pi dissociation from
myosinS1-mdADP-Pi on thin filament (actin subunit) concentration is:
2x103 M1s1 (no rigor myosin, pCa>8), 5.9x104 M1s1 (rigor myosin,
pCa>8), 1.3x105 M1s1 (no rigor myosin, pCa<4), and 1.8x105 M1s1
(rigor myosin, pCa<4). The second order rate constant of the dependence of
the kobs of mdADP dissociation from myosinS1-mADP on thin filament con-
centration is: 4.2x104 M1s1 (no rigor myosin, pCa>8), 2.3x105 M1s1
(rigor myosin, pCa>8), 6.2x105 M1s1 (no rigor myosin, pCa<4), and
1.2x106 M1s1 (rigor myosin, pCa<4). Thus, neither calcium nor rigor myo-
sin is sufficient to maximally activate thin filament acceleration of product dis-
sociation on its own. Full activation requires both calcium and rigor myosin to
be bound to the thin filament. These results are (i) similar to data previously
obtained at low ionic strength; (ii) inconsistent with models which predict
that rigor myosin fully activates the thin filament and (iii) support a mechanism
of thin filament regulation in which the principal regulated step of the hydroly-
sis cycle is phosphate dissociation from actomyosin-ADP-Pi.
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S-Nitrosylation Decreases Ca2D Sensitivity and Actomyosin ATPase
Activity of Contractile Proteins in Cardiac Myofibrils
Cicero Figueiredo-Freitas1,2, Michael W. Foster3, Leonardo Nogueira4,
Jingsheng Liang5, Aline Yamashita1, Raul Dulce6, J. Will Thompson7,
Joshua M. Hare6, M. Arthur Moseley7, Martha M. Sorenson1, Jose´ R. Pinto2.
1Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 2Biomedical
Sciences Department, College of Medicine, Florida State University,
Tallahassee, FL, USA, 3Pulmonary, Allergy and Critical Care Medicine,
Duke University Medical Center, Durham, NC, USA, 4Department of
Medicine, University of California, San Diego, La Jolla, CA, USA,
5Department of Molecular and Cellular Pharmacology, University of Miami
Miller School of Medicine, Miami, FL, USA, 6ISCI, University of Miami
Miller School of Medicine, Miami, FL, USA, 7Institute for Genome Sciences
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Increases in muscle nitric-oxide (NO) production can be buffered by reaction
with intracellular glutathione, forming S-nitrosoglutathione (GSNO). GSNO
has been shown to S-nitrosylate Cys thiols of cardiac contractile proteins
in vivo and in vitro, but effects on maximal force, thin-filament Ca2þ sensitivity
and actomyosin ATPase activity are unknown. Here, we analyzed the targets of
S-nitrosylation in mouse cardiac contractile proteins, and examined the effects
of these modifications on function in myocytes and skinned cardiac myofibrils.
S-Nitrosylation and denitrosylation were detected using resin-assisted capture
(SNO-RAC) and targets for S-nitrosylation were identified by quantitative
LC-MS/MS. Isolated cardiomyocytes treated with S-nitrosocysteine (CysNO,
500mM, 10min) showed an increase in total protein-SNO, followed by progres-
sive denitrosylation (30-60min with CysNO). At 10min, CysNO dose-dependently increased S-nitrosylation of specific Cys thiols in myosin heavy
chain, actin, TnC, TnI, myosin-binding protein C and other muscle proteins.
Myofibril thin-filament Ca2þ sensitivity decreased (P<0.05) after in-vitro treat-
ment with pharmacological GSNO concentrations (1, 10, 100 mM), but maxi-
mum force did not change (P>0.05). Loss of Ca2þ sensitivity was partially
reversed by the denitrosation agent, ascorbate. Relaxation kinetics of skinned
fibers, as measured by flash photolysis, were also significantly reduced
by100mMGSNO (k1,15.33 to 11.68/s; k2 2.33 to 0.87/s; fit to double exponen-
tial). Maximal myofibrillar ATPase activity (pCa 5.0) was also dose-
dependently inhibited (8, 15, 30%) by 50, 100 and 500mM GSNO, an effect
that was reversed by ascorbate. The findings suggest that S-nitrosylation of reg-
ulatory Cys thiol(s) can reversibly modulate cardiac muscle contraction and
may be able to protect the heart by reducing myosin ATPase demand without
affecting the maximal force of contraction.
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A Novel Role of Caldesmon during Smooth Muscle Relaxation
Chih-Lueh Albert Wang, Toshio Kitazawa.
Boston Biomedical Research Institute, Watertown, MA, USA.
The effect of h-caldesmon (h-CaD) on smooth muscle contractility was exam-
ined by force measurements on tissues isolated from wild-type (WT) and h-
CaD-null (KO) mice. Both aorta and tail arteries from KO mice relaxed
more slowly than that from WT animals. The force decay of beta-escin-
permeabilized, kinase-inhibited tissues under pCa>9 was best fitted with
a two-exponential process. We found that the apparently slower relaxation
for the KO samples was not due to lower rate constants, but rather, was because
of increased amplitude of the slower component of the decay. To search for an
explanation for the observed relaxation kinetics, we drew some lessons from
the work done on striated muscles. Muscle relaxation involves two major
events: crossbridge detachment and change of the thin filament from active
to inactive state. The latter occurs first, corresponding to the initial lag phase,
followed by the rapid force decay, the crossbridge detachment. In smooth mus-
cle, the lag phase is ascribed to myosin dephosphorylation, but it may also in-
clude the filament state change, i.e., CaD-tropomyosin moving to a position on
actin filaments that hinders myosin binding. This ‘‘off-position’’ is under strain,
because the dephosphorylated crossbridges are still attached. Assuming that
there are two possible positions for CaD-tropomyosin to occupy, one displacing
the bound myosin more promptly than the other, the crossbridge would detach
at two different rates, resulting in the observed biphasic decay. Our data then
suggest that when h-CaD is absent, fewer tropomyosin molecules are at the
blocking position. Thus, the return of smooth muscle tropomyosin to the proper
inhibitory position upon relaxation needs help from h-CaD. In striated muscle
the movement of tropomyosin was shown to be facilitated by troponin subunits.
CaD may play a troponin-like role in smooth muscle both structurally and
functionally.
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Stable Double-Headed Structure is Essential not only for the Inhibited
State, but also for the Fully Activated State of Smooth Muscle Myosin
Rong-Na Ma1, Katsuhide Mabuchi2, Jing Li1, Zekuan Lu1, Xiang-dong Li1.
1Institute of Zoology, Chinese Academy of Sciences, Beijing, China, 2Boston
Biomedical Research Institute, Watertown, MA, USA.
It is generally accepted that dephosphorylation of regulatory light chain (RLC)
induces the interactions between the two heads of smooth muscle myosin (Sm)
and between the head and the tail, thus inhibiting the motor activity, and phos-
phorylation of RLC interrupts above interactions, thus reversing the inhibition
and stimulating the motor activity to maximal value. Thus it is predicted that
Sm subfragment-1 (S1) containing only one head without the tail is fully active.
However, no solid evident so far supports this prediction, although early studies
showed that S1 produced by limited protease treatment is partially active. Here
we produced a number of Sm truncations with various length of the tail. The
stability of double-headed structure of Sm is dependent on the length of the
coiled-coil tail. The Sm truncations with coiled-coil longer than 214 amino
acids form stable double-headed structure (stable HMM), those with coiled-
coil shorter than 179 amino acids form unstable double headed structure (unsta-
ble HMM), and that without coiled-coil, i.e. S1, is completely single-headed.
Phosphorylation of RLC regulates the motor activity of stable HMM com-
pletely, regulates that of unstable HMM partially, and does not regulate that
of S1. Unexpectedly, the actin-activated ATPase activity of S1, either unphos-
phorylated or phosphorylated, is higher than that of unphosphorylated stable
HMM but less than 10% of that of phosphorylated stable HMM. The actin-
activated ATPase activities of unphosphorylated Sm truncations increase
with the shortening of the coiled-coil tail, and that of phosphorylated Sm trun-
cations decrease with the shortening of the coiled-coil tail. These results indi-
cate that the stable double-headed structure is critical not only for the inhibited
